Setback for EU deal on hormone-disrupting chemicals

Image
AFP Strasbourg
Last Updated : Oct 04 2017 | 11:32 PM IST
The EU's efforts to regulate chemicals which can potentially disrupt the body's hormones suffered a setback today when MEPs blocked a key proposal.
The European Parliament voted against a list produced by the European Commission of criteria to help identify what are known as endocrine disruptors in products used to protect farm animals and plants from disease and insects.
Endocrine disruptors are believed to have a role in many health conditions, from obesity to infertility, and are found in many common goods such as cosmetics or even toys.
"Parliament blocked an EU Commission proposal which would have exempted some chemicals in pesticides from being identified as endocrine disruptors, on Wednesday," parliament said in a statement.
It accused the commission, the executive arm of the 28- nation bloc, of "exceeding its mandate".
The setback came just three months after an apparent breakthrough in a three-year stand-off over the chemicals, when EU member states approved the commission's list.
EU Health Commissioner Vytenis Andriukaitis said in a statement that he "regrets" the parliament decision, adding that "in this case no deal is a bad deal for EU citizens."
"The commission will now need to reflect on next steps to take," he said.
The body's endocrine system -- in the ovaries and testes, as well as the adrenal, pituitary and thyroid glands -- produce hormones that are secreted into the bloodstream to control and coordinate a range of critical body functions.
These hormones help regulate energy levels, reproduction, growth, development, as well as our response to stress and injury.
The disruptors issue has pitted industry and agriculture against consumer and environmental groups for many years.
The EU even announced last year that it had reached broad agreement on what substances were involved but had to go back to the drawing board amid controversy.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Oct 04 2017 | 11:32 PM IST

Next Story